Tango Therapeutics, Inc.
TNGX
$1.21
-$0.06-4.72%
| Weiss Ratings | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.22 | |||
| Price History | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -17.69% | |||
| 30-Day Total Return | -47.39% | |||
| 60-Day Total Return | -58.63% | |||
| 90-Day Total Return | -68.16% | |||
| Year to Date Total Return | -61.34% | |||
| 1-Year Total Return | -83.71% | |||
| 2-Year Total Return | -73.23% | |||
| 3-Year Total Return | -84.12% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -89.43% | |||
| 52-Week Low % Change | 13.90% | |||
| Price | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.02 | |||
| 52-Week Low Price | $1.12 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Aug 26, 2024 | |||
| Valuation | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 137.30M | |||
| Enterprise Value | -84.13M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.20 | |||
| Earnings Per Share Growth | 9.47% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.28 | |||
| Price/Book (Q) | 0.69 | |||
| Enterprise Value/Revenue (TTM) | -2.00 | |||
| Price | $1.21 | |||
| Enterprise Value/EBITDA (TTM) | 0.59 | |||
| Enterprise Value/EBIT | 0.58 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 108.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 857 320 4900 | |||
| Address | 201 Brookline Avenue Boston, MA 02215 | |||
| Website | www.tangotx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -346.07% | |||
| Profit Margin | -309.72% | |||
| Management Effectiveness | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -25.31% | |||
| Return on Equity | -- | |||
| Income Statement | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 42.07M | |||
| Total Revenue (TTM) | 42.07M | |||
| Revenue Per Share | $0.39 | |||
| Gross Profit (TTM) | -101.85M | |||
| EBITDA (TTM) | -143.10M | |||
| EBIT (TTM) | -145.60M | |||
| Net Income (TTM) | -130.30M | |||
| Net Income Avl. to Common (TTM) | -130.30M | |||
| Total Revenue Growth (Q YOY) | -24.19% | |||
| Earnings Growth (Q YOY) | -22.45% | |||
| EPS Diluted (TTM) | -1.20 | |||
| EPS Diluted Growth (Q YOY) | -9.54% | |||
| Balance Sheet | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 257.92M | |||
| Cash Per Share (Q) | $2.37 | |||
| Total Current Assets (Q) | 266.34M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 199.52M | |||
| Current Ratio (Q) | 6.978 | |||
| Book Value Per Share (Q) | $1.85 | |||
| Total Assets (Q) | 316.49M | |||
| Total Current Liabilities (Q) | 38.17M | |||
| Total Debt (Q) | 36.49M | |||
| Total Liabilities (Q) | 116.98M | |||
| Total Common Equity (Q) | 199.52M | |||
| Cash Flow | TNGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 86.13M | |||
| Cash from Financing (TTM) | 47.66M | |||
| Net Change in Cash (TTM) | 2.29M | |||
| Levered Free Cash Flow (TTM) | -67.27M | |||
| Cash from Operations (TTM) | -131.50M | |||
